Page last updated: 2024-12-07

isohumulone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Isohumulone is a bitter compound found in hops, which are used in brewing beer. It is produced by the hop plant during its maturation process and is one of the primary contributors to the bitter taste of beer. Isohumulone is a prenylated chalcone derivative, synthesized via a complex series of enzymatic reactions. The biosynthesis of isohumulone involves several enzymes, including chalcone synthase, prenyltransferase, and oxidase enzymes. Isohumulone is responsible for the characteristic bitterness of beer, which is a desired attribute in many beer styles. It also contributes to the flavor and aroma of beer, although its contribution to aroma is less pronounced than that of other hop compounds. Isohumulone has been shown to possess antioxidant properties, and some research suggests that it may have health benefits. The study of isohumulone is driven by its importance in the brewing industry, its potential health benefits, and its unique chemical structure.'

isohumulone: hop-derived compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID93090
CHEBI ID197058
SCHEMBL ID316229
MeSH IDM0216659

Synonyms (19)

Synonym
isohumulone
3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-enyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one
CHEBI:197058
isohumulone a
3,4-dihydroxy-5-(3-methylbut-2-enyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1-oxopent-3-enyl)cyclopent-2-en-1-one
25522-96-7
unii-e2s413495y
einecs 247-072-1
e2s413495y ,
SCHEMBL316229
3-penten-1-one, 1-[1,2-dihydroxy-3-isovaleryl-5-(3-methyl-2-butenyl)-4-oxo-2-cyclopenten-1-yl]-4-methyl-
QARXXMMQVDCYGZ-UHFFFAOYSA-N
2-cyclopenten-1-one, 3,4-dihydroxy-5-(3-methyl-2-butenyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1-oxo-3-pentenyl)-
3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methyl-2-butenyl)-4-(4-methyl-3-pentenoyl)-2-cyclopenten-1-one #
3,4-dihydroxy-5-(3-methylbut-2-en-1-yl)-2-(3-methylbutanoyl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one
3,4-dihydroxy-5-(3-methylbut-2-enyl)-2-(3-methyl-1-oxobutyl)-4-(4-methyl-1-oxopent-3-enyl)-1-cyclopent-2-enone
Q3155510
DTXSID90948427
3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbut-2-en-1-yl)-4-(4-methylpent-3-enoyl)cyclopent-2-en-1-one

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Isohumulone treatment did not result in significant body weight gain, although pioglitazone treatment did increase body weight (10.6% increase versus control group)."( Isohumulones, bitter acids derived from hops, activate both peroxisome proliferator-activated receptor alpha and gamma and reduce insulin resistance.
Ezaki, O; Fujiwara, D; Ikeshima, E; Kanaya, T; Kondo, K; Odai, H; Oikawa, S; Shiraki, M; Tsuboyama-Kasaoka, N; Yajima, H, 2004
)
2.49

Bioavailability

ExcerptReferenceRelevance
" The most important pharmacokinetic parameters (C(max), t(max), half life, clearance, and AUC(0-∞)) and the absolute bioavailability were determined for each class of hop acid."( Bioavailability of hop-derived iso-α-acids and reduced derivatives.
Boussery, K; Bracke, M; Cattoor, K; De Keukeleire, D; Deforce, D; Heyerick, A; Remon, JP; Van Bocxlaer, J, 2011
)
0.37

Dosage Studied

ExcerptRelevanceReference
" dosing to New Zealand white rabbits, the absolute bioavailability for IAA was determined to be 13."( Bioavailability of hop-derived iso-α-acids and reduced derivatives.
Boussery, K; Bracke, M; Cattoor, K; De Keukeleire, D; Deforce, D; Heyerick, A; Remon, JP; Van Bocxlaer, J, 2011
)
0.37
" Diet-induced obese mice (DIO) were dosed orally with KDT501 and acute effects on glucose homeostasis determined."( Intestinal bitter taste receptor activation alters hormone secretion and imparts metabolic benefits.
Albert, V; Behrens, M; Bland, JS; Fang, M; Galmozzi, A; Godio, C; Grayson, N; Kim, SM; Kim, W; Kok, BP; Littlejohn, NK; Meyerhof, W; Saez, E; Siuzdak, G; Srinivasan, S, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
monoterpenoidAny terpenoid derived from a monoterpene. The term includes compounds in which the C10 skeleton of the parent monoterpene has been rearranged or modified by the removal of one or more skeletal atoms (generally methyl groups).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (10.00)18.2507
2000's12 (60.00)29.6817
2010's6 (30.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 34.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index34.61 (24.57)
Research Supply Index3.22 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index42.51 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (34.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (14.29%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]